Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 6830895, 7 pages
http://dx.doi.org/10.1155/2016/6830895
Research Article

Immunity Status of Blood Donors Regarding Toxoplasma gondii Infection in a Low-Income District of Abidjan, Côte d’Ivoire, West Africa

1Immunology and Allergology Department, UFR Medical Sciences in Abidjan, Felix Houphouet Boigny University, Abidjan, Côte d’Ivoire
2National Blood Transfusion Center, Abidjan, Côte d’Ivoire
3Medical and Technical Parasitology Department, Felix Houphouet Boigny University, Abidjan, Côte d’Ivoire

Received 6 June 2016; Accepted 15 August 2016

Academic Editor: Kurt Blaser

Copyright © 2016 Liliane Siransy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Robert-Gangneux and M.-L. Dardé, “Epidemiology of and diagnostic strategies for toxoplasmosis,” Clinical Microbiology Reviews, vol. 25, no. 2, pp. 264–296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Dumas, M. Cazaux, and M. Ferly-Therizol, “Epidémiologie de la toxoplasmose en Côte d’Ivoire,” Bulletin de la Société de Pathologie Exotique, vol. 82, pp. 283–285, 1989. View at Google Scholar
  3. K. D. Adoubryn, J. Ouhon, J. Nemer, C. G. Yapo, and A. Assoumou, “Dépistage sérologique de la toxoplasmose acquise chez les femmes en âge de procréer dans la commune de Yopougon (Abidjan, Côte d’Ivoire),” Bulletin de la Societe de Pathologie Exotique, vol. 97, pp. 345–348, 2004. View at Google Scholar
  4. K. D. Kouakou, E. A. Kassi, and J. Ouhon, “Aspects évolutifs du sérodiagnostic de la Toxoplasmose en Côte d'Ivoire,” Publications Médicales Africaines, vol. 126, pp. 15–20, 1993. View at Google Scholar
  5. J.-P. Nozais, J. Doucet, L. Tiacoh, and M. Gueunier, “Etude de la prévalence de la toxoplasmose en Côte d’Ivoire. (Résultats portant sur 4769 sérums étudiés par immunofluorescence),” Medecine Tropicale, vol. 35, pp. 413–417, 1975. View at Google Scholar
  6. Université Médicale Virtuelle Francophone, Association Française des Enseignants de Parasitologie et Mycologie (ANOFEL), Toxoplasmose, 2014, http://campus.cerimes.fr/parasitologie/enseignement/toxoplasmose/site/html/cours.pdf.
  7. F. Derouin and H. Pelloux, “Prevention of toxoplasmosis in transplant patients,” Clinical Microbiology and Infection, vol. 14, no. 12, pp. 1089–1101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Izadi, N. J. Jafari, A. M. Poornaki et al., “Detection of Toxoplasma gondii from clinical specimens of patients receiving renal transplant using ELISA and PCR,” Nephro-Urology Monthly, vol. 5, no. 5, pp. 983–987, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Sarkari, R. Shafiei, M. Zare, S. Sohrabpour, and L. Kasraian, “Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran,” Journal of Infection in Developing Countries, vol. 8, no. 4, pp. 543–547, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Nelson, D. J. Kauffmann, D. Ciavarella, and W. J. Senisi, “Acquired toxoplasmic retinochoroiditis after platelet transfusions,” Annals of Ophthalmology, vol. 21, no. 7, pp. 253–254, 1989. View at Google Scholar · View at Scopus
  11. R. S. Barsoum, “Parasitic infections in transplant recipients,” Nature Clinical Practice Nephrology, vol. 2, no. 9, pp. 490–503, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. Groupe de Travail Afssaps, EFS, INTS, and InVS, “Estimation quantitative du risque de contamination d’un don de sang par des agents infectieux,” in Toxoplasmose, pp. 46–47, Institut de Veille Sanitaire, 2007, http://opac.invs.sante.fr/doc_num.php?explnum_id=3527. View at Google Scholar
  13. A. Ebrahim Zadeh, “Toxoplasmosis as a complication of transfusion in hemodialysis patients,” Iranian Journal of Pediatric Hematology and Oncology, vol. 4, pp. 22–25, 2014. View at Google Scholar
  14. A. Kouassi, M. Bengue, L. Siransy Bogui et al., “Séroprévalences des hépatites virales B et C et de l’infection à VIH chez les donneurs de sang en Côte d’Ivoire en 2010,” Revue Bio-Africa, vol. 10, pp. 47–53, 2010. View at Google Scholar
  15. J. Doucet, M.-A. Pothier, and C. L. Castanier, “Premiers résultats sur l'application de la technique d'immunofluorescence indirecte à l'étude de la toxoplasmose à Abidjan,” Lyon Médical, vol. 225, no. 3, pp. 199–200, 1971. View at Google Scholar
  16. I. Maïga, P. Kiemtoré, and A. Tounkara, “Prévalence des anticorps antitoxoplasmiques chez les malades atteints du syndrome d'immunodéficience acquise et les donneurs de sang à Bamako,” Bulletin de la Société de Pathologie Exotique, vol. 94, pp. 268–270, 2001. View at Google Scholar
  17. L. J. Pangui, O. B. Gbati, A. R. Kamga Waladjo, and S. N. Bakou, “Point sur la toxoplasmose en Afrique de l'ouest et du centre, Ecole internationale des Sciences et Médecine vétérinaire,” Revue Africaine de Santé et de Productions Animales, vol. 11, pp. 29–40, 2007. View at Google Scholar
  18. A. Gashout, A. Amro, M. Erhuma et al., “Molecular diagnosis of Toxoplasma gondii infection in Libya,” BMC Infectious Diseases, vol. 16, article 157, 2016. View at Publisher · View at Google Scholar
  19. Centre National de Référence de la Toxoplasmose, “Rapport annuel d’activités 2013, France,” http://cnrtoxoplasmose.chu-reims.fr/wp-content/uploads/2014/09/RAPPORT-CNR-Toxoplasmose-2013.pdf.
  20. Haute Autorité de Santé, France, Recommandations en santé publique: Surveillance sérologique et prévention de la toxoplasmose et de la rubéole au cours de la grossesse, Synthèse, 2009, http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-12/depistages_prenatals_obligatoires__synthese_vf.pdf.
  21. C. Alvarado-Esquivel, M. F. Mercado-Suarez, A. Rodríguez-Briones et al., “Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico,” BMC Infectious Diseases, vol. 7, article 75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. T.-Y. Chiang, H.-H. Hsieh, M.-C. Kuo et al., “Seroepidemiology of Toxoplasma gondii infection among Healthy Blood Donors in Taiwan,” PLoS ONE, vol. 7, no. 10, Article ID e48139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Elhence, P. Agarwal, K. N. Prasad, and R. K. Chaudhary, “Seroprevalence of Toxoplasma gondii antibodies in North Indian blood donors: implications for transfusion transmissible toxoplasmosis,” Transfusion and Apheresis Science, vol. 43, no. 1, pp. 37–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Bamba, D. A. Some, C. Chemla, R. Geers, T. R. Guiguemde, and I. Villena, “Analyse sérologique de la toxoplasmose pergravidique: Évaluation des risques et perspectives du dépistage prénatal au centre hospitalier universitaire de bobo dioulasso au burkina faso,” Pan African Medical Journal, vol. 12, article 43, 2012. View at Google Scholar · View at Scopus
  25. B. M. Mickoto, J.-P. Akue, U. Bisvigou, S. M. Tsonga, and D. Nkoghe, “Étude sérologique de la toxoplasmose chez les femmes enceintes de Franceville, Gabon,” Bulletin de la Société de Pathologie Exotique, vol. 103, no. 1, pp. 41–43, 2010. View at Publisher · View at Google Scholar
  26. B. El Mansouri, M. Rhajaoui, F. Sebti et al., “Seroprevalence of toxoplasmosis in pregnant women in Rabat, Morocco,” Bulletin de la Societe de Pathologie Exotique, vol. 100, no. 4, pp. 289–290, 2007. View at Google Scholar · View at Scopus
  27. J. Havlícek, Z. Gašová, A. P. Smith, K. Zvára, and J. Flegr, “Decrease of psychomotor performance in subjects with latent ‘asymptomatic’ toxoplasmosis,” Parasitology, vol. 122, no. 5, pp. 515–520, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Flegr, J. Klose, M. Novotná, M. Berenreitterová, and J. Havlícek, “Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study,” BMC Infectious Diseases, vol. 9, article 72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Räisänen, “Toxoplasmosis transmitted by blood transfusions,” Transfusion, vol. 18, no. 3, pp. 329–332, 1978. View at Publisher · View at Google Scholar · View at Scopus
  30. E. S. Stuart, N. L. Milford, H. G. Albert et al., “Transmission of toxoplasmosis by leukocyte transfusion,” BLood, vol. 37, no. 4, pp. 388–394, 1971. View at Google Scholar